BTIG's Thomas Shrader joins BiotechTV for Analyst Thursdays from San Francisco
- blonca9
- Mar 28, 2024
- 1 min read
Thomas Shrader shares his thoughts on biotech and comments on Stoke, Denali, Alector, Verona, Esperion, Vaxcyte, Biohaven, Athira, and INmune.